Follow-up monitoring and dose escalation schedule
59 The increased spleen weight was attributed to elevated T-cell and B-cell numbers, while only neutrophil counts were increased in the peripheral blood
Yes, GLP-1s are an exciting and ground-breaking innovation, but its important to put the breakthrough in context and keep the bigger picture in mind
- Sources 1 Neuroscience and Biobehavioral Reviews | The Pharmacology of Amphetamine and Methylphenidate: Relevance to the Neurobiology of Attention-Deficit/Hyperactivity Disorder and Other Psychiatric Comorbidities 2 CNS Spectrums | Lisdexamfetamine Dimesylate: A Prodrug Stimulant for the Treatment of ADHD in Children and Adults 3 Biomolecules and Therapeutics | Potential for Dependence on Lisdexamfetamine - In vivo and In vitro Aspects 4 Future Medicinal Chemistry | Cytochrome P450-activated prodrugs
Retatrutide Name: Retatrutide Manufacturer: Eli Lilly Current stage: Phase III results expected late 2025/2026 Takeaway: If licensed, it could be more effective for weight loss than other GLP-1s
Although several investigations have revealed that D-allulose has antidiabetes activity, the mechanism has yet to be fully elucidated
